Evidence map›Paper›PMID 38752116›Full record

ReviewFood science and biotechnology2024

Review of fish protein hydrolysates: production methods, antioxidant and antimicrobial activity and nanoencapsulation.

Mahrokh Nemati, Seyed Rasoul Shahosseini, Peiman Ariaii

Abstract readReview
In one paragraph

Review in Food science and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Shiga Toxin-ProducingVeterinary sciences · 2026
    Review
  5. Simulated Gastrointestinal Digestion of Tilapia (Foods (Basel, Switzerland) · 2026
    Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mahrokh NematiDepartment of Fisheries Science, Qaemshahr Branch, Islamic Azad University, Qaemshahr, Iran.ORCID 0000-0001-9148-9638
Seyed Rasoul ShahosseiniDepartment of Food Science and Technology, Nour Branch, Islamic Azad University, Nour, Iran.
Peiman AriaiiDepartment of Food Science and Technology, Ayatollah Amoli Branch, Islamic Azad University, Amol, Iran.ORCID https://orcid.org/0000-0001-6383-2814

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Marine products have gained popularity due to their valuable components, especially protein, despite generating significant waste. Protein hydrolysates are widely recognized as the most effective method for transforming these low-value raw materials into high-value products. Fish protein hydrolysate (FPH), sourced from various aquatic wastes such as bones, scales, skin, and others, is rich in protein for value-added products. However, the hydrophobic peptides have limitations like an unpleasant taste and high solubility. Microencapsulation techniques provide a scientific approach to address these limitations and safeguard bioactive peptides. This review examines current research on FPH production methods and their antioxidant and antibacterial activities. Enzymatic hydrolysis using commercial enzymes is identified as the optimal method, and the antioxidant and antibacterial properties of FPH are substantiated. Microencapsulation using nanoliposomes effectively extends the inhibitory activity and enhances antioxidant and antibacterial capacities. Nevertheless, more research is needed to mitigate the bitter taste associated with FPH and enhance sensory attributes.

Indexed as

Bioactive peptidesEnzymatic hydrolysisHydrolysatesNano-carriersNanoliposomes

Identifiers

PMID38752116
PMCPMC11091024

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.